Skip to main content

Personalis, Inc.

PSNL
Exchange
Nasdaq
Industry
Services-Medical Laboratories
SEC CIK
0001527753

In the last 90 days, Personalis, Inc. insiders filed 0 open-market purchases and 6 sales; 158 institutions reported holding it in 13F filings for Q2 2026, worth $1.14B in total; ARK Invest is the only superinvestor holding it.

Q2 2023 vs. Q1 2023

How the institutions holding Personalis, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of PSNL: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders6366+3
Shares27.1M26.1M−1.01M (−3.7%)
Value$75.0M$49.0M−$26.0M (−34.7%)

New holders (7)

Institutions that held Personalis, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to PSNL in Q2 2023
InstitutionSharesValue% of portfolio
Gsa Capital Partners LLP30,534$57.0K0.01%
HRT Financial LP19,904$37.0K0.00%
Envestnet Asset Management Inc13,072$24.6K0.00%
Bragg Financial Advisors, Inc12,644$23.8K0.00%
Rhumbline Advisers3,709$6.97K0.00%
First Horizon Advisors, Inc.900$1.69K0.00%
Sofos Investments, Inc.2$80.00%

Sold out (4)

Institutions that held Personalis, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of PSNL in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Susquehanna International Group, LLP97,479$269.0K
Jane Street Group, LLC90,494$249.8K
Engineers Gate Manager LP12,942$35.7K
IFP Advisors, Inc124–